FdaApplication
BLA 761326
Identifiers
- fda_app_no: BLA761326
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 2026-03-26 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AWIQLI | INSULIN ICODEC | 2,100UNITS/3ML (700UNITS/ML) | Injection |
| AWIQLI | — | 1,050UNITS/1.5ML (700UNITS/ML) | Injection |
| AWIQLI | — | 700UNITS/ML | Injection |
3 products